Search tips
Search criteria 


Logo of brjopthalBritish Journal of OphthalmologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Br J Ophthalmol. 1990 June; 74(6): 344–349.
PMCID: PMC1042124

Cyclosporin in the treatment of severe chronic idiopathic uveitis.


In a randomised double-masked study of 27 patients with a severe chronic idiopathic uveitis we evaluated the efficacy, safety, and tolerability of cyclosporin. All received prednisone in a low dose (0.3 mg/kg/day). In 14 patients this was combined with cyclosporin in a single daily dose of 10 mg/kg/day, while 13 patients received a placebo. The dosages were tapered off in accordance with a protocol, and we compared the number of months of successful therapy before the uveitis relapsed. The efficacy results, as expressed in a Kaplan-Meier curve, were in favour of cyclosporin. Owing to the small sample size, however, this difference did not reach statistical significance. The immunosuppressive effect of cyclosporin was not permanent, and in all but one patient the intraocular inflammation relapsed on reduction of dosage. Rather small cumulative doses of cyclosporin proved to be nephrotoxic, but subjective tolerability for cyclosporin was good.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987 Feb 15;103(2):131–136. [PubMed]
  • Ringdén O. Cyclosporine in allogeneic bone marrow transplantation. Transplantation. 1986 Nov;42(5):445–452. [PubMed]
  • Deeg HJ, Storb R, Gerhard-Miller L, Shulman HM, Weiden PL, Thomas ED. Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance. Transplantation. 1980 Mar;29(3):230–235. [PubMed]
  • Schulak JA, Monson D, Shelby J, Corry RJ. Abrogation of second-set rejection with cyclosporine. Transplantation. 1983 Sep;36(3):289–293. [PubMed]
  • Mochizuki M, Nussenblatt RB, Kuwabara T, Gery I. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci. 1985 Feb;26(2):226–232. [PubMed]
  • Fite KV, Pardue S, Bengston L, Hayden D, Smyth JR., Jr Effects of cyclosporine in spontaneous, posterior uveitis. Curr Eye Res. 1986 Oct;5(10):787–796. [PubMed]
  • Striph G, Doft B, Rabin B, Johnson B. Retina S antigen-induced uveitis. The efficacy of cyclosporine and corticosteroids in treatment. Arch Ophthalmol. 1986 Jan;104(1):114–117. [PubMed]
  • Nussenblatt RB, Rodrigues MM, Salinas-Carmona MC, Gery I, Cevario S, Wacker W. Modulation of experimental autoimmune uveitis with cyclosporin A. Arch Ophthalmol. 1982 Jul;100(7):1146–1149. [PubMed]
  • Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983 Sep;96(3):275–282. [PubMed]
  • Nissen C, Bendtzen K, Tvede N, Andersen V. The treatment of presumed non-infective uveitis with cyclosporin A. Acta Ophthalmol Suppl. 1985;173:72–73. [PubMed]
  • Quentin CD, Vogel M. Ciclosporin-Behandlung bei Uveitis. Klin Monbl Augenheilkd. 1986 Mar;188(3):248–250. [PubMed]
  • Müftüoğlu AU, Pazarli H, Yurdakul S, Yazici H, Ulkü BY, Tüzün Y, Serdaroğlu S, Altuğ E, Bahçecioğlu H, Güngen G. Short term cyclosporin A treatment of Behçet's disease. Br J Ophthalmol. 1987 May;71(5):387–390. [PMC free article] [PubMed]
  • Graham EM, Sanders MD, James DG, Hamblin A, Kasp Grochowska E, Dumonde D. Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K. 1985;104(Pt 2):146–151. [PubMed]
  • Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum. 1985 Jun;28(6):671–679. [PubMed]
  • Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology. 1980 Feb;87(2):109–121. [PubMed]
  • Benezra D, Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol. 1986 Aug;70(8):589–592. [PMC free article] [PubMed]
  • HOGAN MJ, KIMURA SJ, THYGESON P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol. 1959 May;47(5 Pt 2):155–170. [PubMed]
  • Johnston A, Marsden JT, Holt DW. The United Kingdom Cyclosporin Quality Assessment Scheme. Ther Drug Monit. 1986;8(2):200–204. [PubMed]
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. [PubMed]
  • Ost L. Effects of cyclosporin on prednisolone metabolism. Lancet. 1984 Feb 25;1(8374):451–451. [PubMed]
  • Langhoff E, Madsen S, Flachs H, Olgaard K, Ladefoged J, Hvidberg EF. Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients. Transplantation. 1985 Jan;39(1):107–109. [PubMed]
  • Frey FJ, Schnetzer A, Horber FF, Frey BM. Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation. Transplantation. 1987 Apr;43(4):494–498. [PubMed]
  • Myers BD. Cyclosporine nephrotoxicity. Kidney Int. 1986 Dec;30(6):964–974. [PubMed]
  • Palestine AG, Austin HA, 3rd, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, Nussenblatt RB. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986 May 15;314(20):1293–1298. [PubMed]
  • Svenson K, Bohman SO, Hällgren R. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med. 1986 Oct;146(10):2007–2010. [PubMed]
  • Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med. 1984 Oct;77(4):652–656. [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group